Transparency data

Non-tech. summaries 2015: projects on the cardiovascular system

Projects granted during 2015 that have a primary purpose of basic research: cardiovascular, blood and lymphatic system.

• From: Home Office
• Published: 21 June 2016

Documents

Non-technical summaries: projects granted in 2015, volume 18

PDF, 827 KB, 125 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This document outlines the projects granted under the Animals (Scientific Procedures) Act 1986 during 2015 with a primary purpose of basic research: cardiovascular, blood and lymphatic system.

It contains a full list of the 36 projects that were granted.

The projects covered are:

• investigation of factors influencing heart failure (heart, hypertension, hormones)

• novel therapeutic approaches to heart disease (heart failure, energetic, metabolism, ischaemia)

• tissue function and metabolism in cardiac disease (heart function metabolism stem cells)

• transcriptional regulation of angiogenesis (angiogenesis, cancer, blood vessels, transcription)

• switching genes on and off in haemopoiesis (gene regulation haemopoiesis)

• testing of novel compounds (mitochondria, heart, pharmokinetics)

• ion regulation and cell signalling in cardiac and skeletal muscle (exercise, heart, heart failure, skeletal muscle, sodium)

• protection after an acute heart attack or stroke (heart, heart attack, stroke, ischaemia, reperfusion injury)

• regulation/role of the ERK1/2 cascade in the heart (heart failure, cancer therapies, protein kinases, hypertension, hypertrophy)

• role of the cytoskeleton in cardiovascular diseases (cytoskeleton, platelet, thrombosis)

• novel treatments for right heart failure (pulmonary artery hypertension, right heart failure, exercise, β-blockers, phosphodiesterase 5 inhibitors)

• functional characterisation of novel blood genes (zebrafish, blood, stem cells, cancer)

• inflammation and cardiovascular disease (blood vessel, thrombosis, aspirin, inflammation, heart attack)

• the long-term effects of prenatal hypoxia on cardiomyocyte function (programming, pre-natal hypoxia, cardiac, mitochondria, myocyte)

• developmental programming by maternal diet (maternal obesity, pregnancy, metabolic syndrome, diet, developmental programming)

• imaging of cardiovascular diseases with novel agents and devices (imaging, cardiovascular disease, diagnosis, therapy)

• autonomic control of cardiac function and rhythm (cardiac function, arrhythmia, autonomic control)

• regulation of thrombus formation (clotting factors, thrombus formation)

• modulation of cardioprotection in pathological states (heart attack, diabetes, age, animal research)

• investigating normal blood development and blood cancer (haematopoiesis, blood stem cell, leukaemia, microenvironment)

• studies on vascular diseases and repair mechanisms (blood vessel, restenosis, stent, vein graft, endothelium)

• zebrafish models of cardiovascular development and disease (cardiovascular, angiogenesis, heart, blood flow)

• mechanisms and therapy for limb ischaemia (limb ischaemia, angiogenesis, arteriogenesis)

• signalling in normal and abnormal blood cell function (blood, cancer, clotting, bone marrow)

• control of adrenal development and function (adrenal, steroid, development, disease, differentiation)

• transverse aortic constriction (TAC) in rodents (heart failure, cardiac hypertrophy, rats, mice)

• the role of platelets in haemostasis and thrombosis (mice, platelet, thrombosis, haemostasis)

• redox mechanisms of organ failure in sepsis (sepsis, redox, blood pressure, multi-organ failure, therapy)

• modelling striated muscle disease in zebrafish (heart, skeletal muscle, popeye genes)

• mechanisms of platelet-driven disease (platelet, cardiovascular, heart attack, thrombosis)

• parental nutrition and offspring development (diet, gamete quality, pre-implantation embryo, offspring health, developmental programming)

• regulation of normal and malignant haemopoiesis (leukaemia, haematology, development, stem cell)

• targeted gene delivery for haemostasis (blood coagulation, haemophilia, thrombosis)

• stem cells for blood and tissue repair (blood, blood vessel, repair, transplantation, regeneration)

• regulation of blood cell generation (blood stem cells, regenerative medicine)

• zebrafish manipulation to study blood development (haematopoiesis, haematopoietic stem cells (HSCs), zebrafish)

• preclinical therapies for renal and cardiovascular injury (kidney injury, cardiac injury, muscle damage, blocked blood flow, therapy)

Published 21 June 2016